[Anti-viral treatment: pro or cons type I IFN?]

Med Sci (Paris). 2013 Oct;29(10):836-9. doi: 10.1051/medsci/20132910008. Epub 2013 Oct 18.
[Article in French]
No abstract available

Publication types

  • News

MeSH terms

  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / therapy
  • Case-Control Studies
  • Chronic Disease
  • Humans
  • Immunity, Innate / physiology
  • Immunotherapy / methods
  • Interferon Type I / adverse effects
  • Interferon Type I / physiology
  • Interferon Type I / therapeutic use*
  • Lupus Erythematosus, Systemic / genetics
  • Lupus Erythematosus, Systemic / immunology
  • Lupus Erythematosus, Systemic / therapy
  • Microarray Analysis
  • Transcriptome
  • Virus Diseases / drug therapy*
  • Virus Diseases / genetics
  • Virus Diseases / immunology

Substances

  • Antiviral Agents
  • Interferon Type I